UNSPSC 51294406: Etoperidone

This classification denotes an antiemetic agent with the molecular formula C19H28ClN5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KAI6MVO39Z, chemically known as 1,2,4-triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-4,5-diethyl-2,4-dihydro- but generally known as etoperidone, which bears US NIH Compound Identifier 40589. European Medicines Agency schedules Etoperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07336MIG.

UNSPSC 51294406 Etoperidone is a Commodity code that in practice does not align with recent state and local procurement activity. The source lists three recent opportunities nominally tagged to this code, but none involve etoperidone procurement—a pharmaceutical ingredient with limited direct procurement by state and local health authorities. Instead, the recent solicitations address naloxone and drug deactivation systems (Seminole County, Florida), a Request for Information on direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), and a cooperative purchasing agreement for generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance covering Minnesota and Oregon). The mismatch between the code's nominal scope and actual buying activity suggests this Commodity code does not reflect how state and local governments currently tag pharmaceutical purchases in practice.

The three opportunities span different issuing-body types and geographic regions. Seminole County is a county health department seeking consumable naloxone units and drug deactivation systems through a competitive bid (IFB 60459723LAS, due July 26, 2023) for quarterly delivery. Texas Health and Human Services Commission issued an RFI to explore vendor capabilities for direct-to-manufacturer pharmacy programs (due April 3, 2026), signaling early-stage procurement intent rather than immediate opportunity. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative vehicle, sought RFP responses for generic pharmaceutical and OTC product contracts covering multiple states (due March 26, 2026), with awards effective July 1, 2026. Activity is concentrated in the South and Upper Midwest; the code shows no clear pattern of repeat buyers or sustained demand under this specific Commodity classification.